InnoCan Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; InnoCan Pharma is scheduled to report earnings on May 28, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 4.89M	$ 4.08M	$ 3.12M	$ 1.56M	$ 1.13M
Gross Profit	$ 4.29M	$ 3.66M	$ 2.66M	$ 1.37M	$ 1.53M
EBIT	$ -1.21M	$ -1.21M	$ -395.00K	$ -1.23M	$ -1.51M
EBITDA	$ -1.20M	$ -1.20M	$ -386.00K	$ -1.22M	-
Net Income Common Stockholders	$ -883.00K	$ -2.03M	$ -520.00K	$ -1.27M	$ -1.21M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.88M	$ 4.02M	$ 3.37M	$ 4.09M	$ 4.95M
Total Assets	$ 6.94M	$ 6.87M	$ 5.90M	$ 6.40M	$ 6.98M
Total Debt	$ 33.00K	$ 16.00K	$ 26.00K	$ 26.00K	$ 34.00K
Net Debt	$ -3.85M	$ -4.01M	$ -3.35M	$ -4.06M	$ -4.91M
Total Liabilities	$ 2.55M	$ 2.37M	$ 899.00K	$ 1.06M	$ 751.00K
Stockholders Equity	$ 4.10M	$ 4.30M	$ 5.01M	$ 5.47M	$ 6.39M
Cash Flow	-
Free Cash Flow	$ -1.32M	$ -719.00K	$ -722.00K	$ -1.19M	$ -1.38M
Operating Cash Flow	$ -1.31M	$ -718.00K	$ -713.00K	$ -1.16M	$ -1.36M
Investing Cash Flow	$ -9.00K	$ -32.00K	$ -9.00K	$ -34.00K	$ -16.00K
Financing Cash Flow	$ 1.12M	$ 1.45M	$ -6.00K	$ 357.00K	$ -2.00K

Currency in USD

InnoCan Pharma Earnings and Revenue History

Income Statement >

InnoCan Pharma Debt to Assets

Balance Sheet >

InnoCan Pharma Cash Flow

Cash Flow >

InnoCan Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing